Annual reports

2020 Annual Report

Read more

2019 Annual Report

Read more

2017 Annual Report

Read more

2018 Annual Report

Read more

Latest

100 miles for Henry In March

Henry is such a strong an amazing little boy, a real inspiration at such a young age. I want to try and help him and his family reach their goal to continue his treatment.
Karen and Evie’s 23 day Squatty Botty

We are taking on the Squatty Botty challenge to raise much needed funds for dear little Ollie
Leeanne Brennan
A Half Marathon for Henry The Brave

Henry has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis. His family need support for his on going treatment.

Most read

Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.
Corey is thriving after neuroblastoma battle

Family donate almost £150,000 to neuroblastoma research
Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

Alexandra Lane was formally voted on and welcomed to our Board of Trustees this week. We are thrilled to welcome Alex to the team.
BEACON study opens in Europe

The much-anticipated BEACON study amendment is now open and recruiting patients.
Steve Richards to step down as Chief Executive

CEO to leave Solving Kids' Cancer after three years in the role.
Solving Kids’ Cancer appoints new Chief Executive Officer

Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.
Ollie’s Appeal

Ollie’s mum and dad are determined to do everything they can to give him the best possible chance of beating neuroblastoma.
Chloe’s Journey

"We have no guarantees but you have helped us to know that we as parents have done all we can to keep Chloe in remission”
Charities fund new clinical trial

Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.
First Three Months

Gail Jackson, CEO, launches her blog. Reflecting on personal resilience, our work and joining Solving Kids' Cancer as COVID hit.